Latest Breaking News On - University of pennsylvania joshuaf baker - Page 1 : comparemela.com

A new study provides insight into the effectiveness of IFX-dyyb in a real-world US population of RA patients, showing how the biosimilar compares to other treatments.

United statesUniversity of pennsylvaniaJoshuaf bakerHealth assessment questionnaireDrug administrationUniversity of pennsylvania joshuaf bakerPerelman school of medicinePerelman schoolClinical disease activity indexRheumatoid arthritisIfx dyybInfliximab biosimilarReal world dataRa in us adultsBus data